[HTML][HTML] Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - Ebiomedicine, 2024 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng… - … - pubmed.ncbi.nlm.nih.gov
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
[HTML][HTML] Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - eBioMedicine, 2024 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease.
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - Ebiomedicine, 2024 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
[HTML][HTML] Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - eBioMedicine, 2024 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
[HTML][HTML] Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - eBioMedicine, 2024 - ncbi.nlm.nih.gov
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease.
X Peng, X Zhang, Z Xu, L Li, X Mo, Z Peng, Z Shan… - Ebiomedicine, 2024 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent risk factor for cognitive
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …
impairment. Cerebral amyloid-β (Aβ) accumulation, as an important pathology of cognitive …